ChemoCentryx DSO Ratio 2011-2026 | CCXI

Annual DSO Ratio ChemoCentryx

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
3.1	0.951	1.79	17.5	226	964	-	-	23.7	77.9	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
964	0.951	164

Quarterly DSO Ratio ChemoCentryx

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	29.2	26.7	9.12	0.44	6.24	1.18	2.5	2.96	0.37	2.61	1.6	1.52	2.24	12.2	11.7	2.54	5.66	252	41.8	261	522	451	564	648	986	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
986	0.37	154

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Amarin Corporation plc AMRN	213	$ 14.67	-	$ 6.09 B	Irlanda
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
CollPlant Biotechnologies Ltd. CLGN	9.68	$ 0.66	-0.45 %	$ 7.56 M	Israel
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
CEL-SCI Corporation CVM	227	$ 3.47	-	$ 221 M	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	2.47	-	-	$ 546 M	USA
Denali Therapeutics DNLI	1.89	$ 19.74	-	$ 3.25 B	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Avid Bioservices CDMO	45.6	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Esperion Therapeutics ESPR	99.7	$ 2.85	-	$ 592 M	USA
EyePoint Pharmaceuticals EYPT	7.32	$ 13.06	-	$ 957 K	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Equillium EQ	16.6	$ 2.06	-	$ 118 M	USA
Eton Pharmaceuticals ETON	39.1	$ 23.45	-	$ 631 M	USA
CRISPR Therapeutics AG CRSP	1.1 K	$ 47.55	-	$ 4.28 B	Schweiz
Arbutus Biopharma Corporation ABUS	50	$ 4.45	-	$ 853 M	Canada